Share this article and save a life!
RFK Jr. just made his biggest healthcare move yet.
Last week, HHS Secretary Kennedy appointed Casey B. Mulligan as Chief Economist and Regulatory Officer.
Why this matters for every healthcare executive:
Mulligan isn’t your typical Washington insider. He’s a University of Chicago economist known for challenging conventional healthcare economics. His appointment signals three seismic shifts:
📊 Data liquidity becomes priority #1
No more data silos. Expect aggressive regulatory pushes for seamless data exchange between hospitals, FQHCs, and payers. If your EHR can’t talk to everyone else’s, you’re about to have a problem.
🤖 AI-enabled systems get fast-tracked
Forget the cautious FDA approach. This administration wants AI integrated into care delivery NOW. Organizations sitting on the AI sidelines will face competitive disadvantages and potential regulatory pressure.
💰 Affordability through competition, not regulation
Mulligan’s economic philosophy: let market forces drive down costs. Expect price transparency requirements on steroids and policies favoring direct-to-consumer healthcare models.
The subtext? Kennedy’s MAHA (Make America Healthy Again) agenda just got its chief architect.
Remember when we thought healthcare transformation would take decades? This administration is compressing that timeline to months.
For FQHCs and safety-net providers: prepare for both opportunities and challenges. Data liquidity could unlock new funding streams, but you’ll need tech infrastructure yesterday.
For imaging centers and radiology groups: AI integration isn’t optional anymore. It’s about to become a regulatory expectation.
The most successful healthcare organizations in 2027 won’t be those with the biggest budgets. They’ll be those who adapted fastest to this new regulatory reality.
What’s your organization doing TODAY to prepare for mandatory data liquidity?
♻️ Repost if healthcare needs radical regulatory reform
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
